Press Releases

Date Title and Summary Additional Formats
Toggle Summary Dynavax Initiates Phase II Clinical Trial of ISS Vacine for Hepatitis B - Study Focuses on Single-Injection Approach
Dynavax Initiates Phase II Clinical Trial of ISS Vacine for Hepatitis B - Study Focuses on Single-Injection Approach Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA, September 4, 2002 - Dynavax Technologies, a privately
View HTML
Toggle Summary Dynavax Names William J. Dawson Vice President, Finance and Operations, and Chief Financial Officer
Dynavax Names William J. Dawson Vice President, Finance and Operations, and Chief Financial Officer Contact: Dynavax Technologies Corporation Dino Dina, M.D. President and CEO 510-848-5100 Berkeley, CA -- August 22, 2002 - Dynavax Technologies Corporation today announced the appointment of William
View HTML
Toggle Summary Dynavax Raises $34.8 Million In Private Equity Round Led By Care Capital
Dynavax Raises $34.8 Million In Private Equity Round Led By Care Capital Contact: Andrew Gengos Chief Financial Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA, April 25, 2002 - Dynavax Technologies, a privately held biopharmaceutical company, today announced that it had raised
View HTML
Toggle Summary Dynavax Names New Vice Presidents
Dynavax Names New Vice Presidents Contact: Dino Dina, M.D. President and CEO Dynavax Technologies Corporation (510) 848-5100 or (877) 848-5100 Berkeley, CA, December 6, 2000 - Dynavax Technologies Corporation today announced that it has named three new vice presidents, including Robert Lee Coffman,
View HTML